ArticleJournal of personalized medicine2022
Multi-Class Classification of Breast Cancer Using 6B-Net with Deep Feature Fusion and Selection Method.
Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Cross-modal attentive fusion network for tri-modal lesion growth prediction.Scientific reports · 2026Article
- Multi-Class Classification of Breast Cancer Subtypes Using ResNet Architectures on Histopathological Images.Journal of imaging · 2025Article
- Artificial intelligence in breast cancer diagnosis: A systematic literature review.Cambridge prisms. Precision medicine · 2025Review
- [Research progress of breast pathology image diagnosis based on deep learning].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2024Review
- Equilibrium Optimization-Based Ensemble CNN Framework for Breast Cancer Multiclass Classification Using Histopathological Image.Diagnostics (Basel, Switzerland) · 2024Article
- Fine tuning deep learning models for breast tumor classification.Scientific reports · 2024Article
- BCDiagnostics (Basel, Switzerland) · 2023Article
- Three-Dimensional Postoperative Results Prediction for Orthognathic Surgery through Deep Learning-Based Alignment Network.Journal of personalized medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Breast cancer has now overtaken lung cancer as the world's most commonly diagnosed cancer, with thousands of new cases per year. Early detection and classification of breast cancer are necessary to overcome the death rate. Recently, many deep learning-based studies have been proposed for automatic diagnosis and classification of this deadly disease, using histopathology images. This study proposed a novel solution for multi-class breast cancer classification from histopathology images using deep learning. For this purpose, a novel 6B-Net deep CNN model, with feature fusion and selection mechanism, was developed for multi-class breast cancer classification. For the evaluation of the proposed method, two large, publicly available datasets, namely, BreaKHis, with eight classes containing 7909 images, and a breast cancer histopathology dataset, containing 3771 images of four classes, were used. The proposed method achieves a multi-class average accuracy of 94.20%, with a classification training time of 226 s in four classes of breast cancer, and a multi-class average accuracy of 90.10%, with a classification training time of 147 s in eight classes of breast cancer. The experimental outcomes show that the proposed method achieves the highest multi-class average accuracy for breast cancer classification, and hence, the proposed method can effectively be applied for early detection and classification of breast cancer to assist the pathologists in early and accurate diagnosis of breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.